The ectopic expression of hnRNPA1 at different disease stages or sites has been progressively proved to be correlated with pathophysiological features and clinical prognosis of cancers, indicating hnRNPA1 as a promising cancer biomarker. This evidence concerns the gene HNRNPA1 and cancer.